Nephron announces new partnership see more
Nephron Pharmaceuticals Corporation, one of the fastest growing pharmaceutical companies in the country, announced a new partnership with One Medical, a leading national digital health and primary care organization that combines 24/7 access to virtual care and digital health tools with COVID-19 testing services to businesses and employees.
“Re-opening businesses, and getting our economy moving again, is one of our highest priorities,” said Nephron CEO Lou Kennedy, who is a member of Governor Henry McMaster’s #accelerateSC, the coordinated COVID-19 advisory team tasked with recommending economic revitalization plans for South Carolina. “Part of the new normal for businesses is testing employees to make sure the workplace is safe. We couldn’t be prouder to offer COVID-19 testing services to our employees and neighbors.”
Kennedy and John Singerling, Chief Network Officer of One Medical and a longstanding healthcare executive based in South Carolina, are working together to make this partnership a reality, hoping that it serves as an example for businesses around the country.
The Nephron CLIA-Certified lab has procured state-of-the-art technology for COVID-19 real-time PCR testing and serological antibody testing for its own employees, and for employees of neighboring businesses. The lab intends to integrate with One Medical’s technology platform, which is capable of supporting a comprehensive workplace reentry COVID-19 testing program. One Medical’s virtual care solutions facilitate scheduling for specimen collection and digitally documenting those test results. It also screens and evaluates clinical risk factors and symptoms and supports employer tracking and reporting needs.
“I am very pleased to be working alongside the Nephron team to leverage One Medical’s digital health platform as a way to help get South Carolinians back to work safely,” said One Medical Chief Network Officer, John Singerling. “Currently working with over 7,000 employers nationwide has allowed One Medical to build a comprehensive workplace reentry program that is grounded in medicine and testing, and powered by our technology, which allows for seamless tracking, tracing and ongoing monitoring.”
SARS-CoV-2 PCR tests diagnose whether a person is infected with the virus by using technology that analyzes viral genetic material. Antibody tests check blood for antibodies. If present, antibodies indicate a person has been previously or is currently infected by the virus.
Nephron Pharmaceuticals Corporation has been on the frontlines of the nationwide COVID-19 response. The West Columbia-based company develops and produces safe, affordable generic inhalation solutions and suspension products that can be used to treat severe respiratory distress symptoms associated with COVID-19. In addition, the company operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. These products are used, many times, to sedate patients and keep them comfortable when health care professionals place them on ventilators in the fight against the virus.
Life sciences in South Carolina is big business -- and getting bigger by the day. Read why... see more
In this article published simultaneously in Charleston Business Magazine, Columbia Business Magazine and Greenville Business Magazine, SCBIO CEO Sam Konduros paints a picture of the diversity of the rapidly-growing life sciences industry, and why the future is exceedingly bright -- and getting brighter -- as the $11.4 billion industry soars to new heights across South Carolina.
Life sciences in South Carolina spans a diverse spectrum—from major pharmaceutical companies to globally known medical device companies.
It encompasses start-ups and early stage innovation companies and embraces prestigious research universities and acclaimed health care systems employing some of America’s finest minds. It includes research and medical labs, bioscience-related distribution, even Bio-Ag tied to the state’s historical agricultural segment. Click to read complete article...
Learn about South Carolina Life Sciences Feb. 20! see more
Industry subject matter experts to cover what businesses need to know
about life sciences, South Carolina’s fastest-growing industry segment
GREENVILLE, SC – February 4, 2019 – SCBIO will host a full day program February 20, 2019 -- Life Sciences Boot Camp: Insights on SC’s Fastest-Growing Industry – to inform and update businesses and professionals from across the state on opportunities, trends and issues facing South Carolina’s fastest-growing industry segment.
To be held at the University of South Carolina’s Alumni Center in Columbia, the program will run from 8:30 a.m. until 4:30 p.m. and will feature a light breakfast followed by presentations from over half a dozen noted life sciences industry leaders. Confirmed presenters and their topics are:
- Tushar Chikhliker, Partner, Nexsen Pruet, “Pharma Industry Challenges Opportunities & Legal Insights”
- Kathy Phlegar, Principal, Phlegar & Associates, “Product Development and Commercialization: The Changing Landscape of Bringing MedTech Products to Market”
- Maureen Thomas, National Institute on Aging/National Institutes on Health, “Early Stage Funding: Accessing SBIR-STTR Capital”
- Erica Jackson, Partner, K&L Gates, “Navigating the FDA: An Overview of Medical Product Approvals and Enforcement Trends”
- Dave McGlashan, Life Sciences Team Architect, DPR Construction, “Optimizing Capability & Efficiency in Your Life Sciences Facility”
- Darralyn Alexander, President, Reimbursement Strategies – “How To Gain Reimbursement For My New Technology”
- Sam Konduros, President & CEO, SCBIO – “South Carolina Life Sciences 2019: A Look Forward”
SCBIO Investor Organizations receive one registration at no charge, and additional attendees from Investor organizations pay only $50 for the entire day. Individual Members of SCBIO pay only $50 for the entire program, while the general public and Non-Members can attend for just $125. To register or for more details, visit the Events page at www.SCBIO.org/.
An additional highlight of the day’s program on “Early Stage Funding: Accessing SBIR-STTR Capital” will be when presenter Maureen Thomas is joined for discussion and open Q&A by Tyler Tatum and Ron Gorman of 3PhaseSC – South Carolina’s only free resource for SBIR/STTR grant consulting. Attendees may also schedule 1-on-1 time for afternoon discussion with Ms. Thomas between 1:15 PM and 3:30 PM for more detailed conversation and guidance.
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries. Life sciences is recognized as the fastest-growing segment of South Carolina’s knowledge economy.
SCBIO is also the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations. SCBIO’s diverse membership is leading research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.
For additional information on SCBIO, visit www.SCBIO.org.
Building the business of life sciences in South Carolina has become the call to action of SCBIO... see more
Building the business of life sciences in South Carolina has become the call to action and theme of the 2017 annual conference of the S.C. Biotechnology Organization (SCBIO). The rapidly evolving statewide industry association is featured in this September 2017 issue of Charleston Business Magazine, and will be featured in October 2017 issues of Columbia Business and Greenville Business as well. Click here for the full article.
South Carolina's life sciences industry is booming. Read on for details... see more
From pharmaceuticals and medical devices to research and laboratory testing, the state's life sciences field is booming. The Charleston and Lowcountry region is home to many established companies and start-ups making a mark on the biomedical and health industries. Read on for the full story from Charleston Business Magazine's 2018 State of the Lowcountry Report.
IVC, which produces dietary supplements, prescription and OTC products, is expanding. see more
Company produces high quality dietary supplements, plus nutritional, prescription and OTC products, for leading U.S. and global retailers and contract customers
GREENVILLE, S.C. – June 18, 2018 – International Vitamin Corporation (IVC), which produces high quality dietary supplements along with nutritional, prescription and OTC products, will invest several million dollars and add a significant number of positions to expand operations at its Greenville County, S.C. facilities over the next several years.
Founded more than 55 years ago, IVC produces high quality dietary supplements for leading food, drug, mass and club retailers in the United States. The company also produces nutritional, prescription and OTC products for contract customers around the world. IVC’s recognized ability to deliver on innovation, quality and supply chain efficiency has enabled IVC to become one of the largest and fastest growing private label nutritional supplement companies in the nutritional marketplace.
“This expansion of our Greenville County presence represents an important step in the growth of our business,” said Steven Dai, President and CEO for International Vitamin Corporation.
“We have found Greenville County and the Upstate a welcoming and pro-business location to expand our business, serve our customers and accelerate IVC’s success as we focus our efforts on meeting growing demand from our customers,” Dai added. “We appreciate the support of the Greenville Area Development Corporation, the city of Greenville, the South Carolina Department of Commerce, and all who joined to make this announcement a reality.”
IVC will expand its operations at 4615 Dairy Road and 4611 Dairy Road in Greenville County, already employing more than 380 associates. IVC will create “a meaningful number of additional skilled and professional positions in Greenville County over the next several years,” said Jill Stambler, Vice President Human Resources.
“Greenville County is pleased with International Vitamin Corporation's decision to expand its business operations in Greenville County by producing well known dietary supplements and pharmaceutical products to the US and international markets as it has for over 50 years,” said H.G. “Butch” Kirven, Chairman of Greenville County Council. “This expansion means significant additional capital investment by the company here, coupled with a commitment to increasing job opportunities for local citizens. The company's decision reflects the high caliber of Greenville county's workforce, our low tax rates, and the unparalleled quality of life unique to our area.”
“IVC’s focus on the vitamins, minerals and supplements market and innovations in both manufacturing and supply chain show that our community continues to be a profitable place to do business,” said City of Greenville Mayor Knox White. “The expansion of their manufacturing facility along the I-85 corridor is further affirmation that Greenville is open for business and we are thankful for the IVC family’s trust and continued investment.”
Hiring details for the additional positions to be filled will be announced in the near future, according to Stambler. She adds, “We are currently looking for a number of positions on different shifts.” Some include:
- Set-up Mechanics
- Material Handlers
- Turret Drivers
- Manufacturing Supervisors
- Warehouse Clerk
- Warehouse Order Pickers
- Warehouse Shippers
Interested candidates may apply directly at the IVC website by visiting http://ivccareers.com.
For more information about International Vitamins Corporation, visit them at www.ivcinc.com.
Avara Pharmaceutical Services finalizes acquisition of GSK Consumer Healthcare facility in South CarolinaAvara Pharmaceutical Services has completed a South Carolina acquisition from GSK see more
Avara Pharmaceutical Services, a world-class contract development and manufacturing organization (CDMO), announced that the acquisition of the GlaxoSmithKline (GSK) consumer healthcare manufacturing facility in Aiken, South Carolina (USA) is complete. Read on for full details...
BIO International Convention, the world’s premier life sciences event, returns to Boston June 4-7 see more
The BIO International Convention, the world’s premier life sciences event, will return to the Boston Convention & Exhibition Center June 4-7, to celebrate 25 years of advocacy and innovation. The 2018 event is expected to attract more than 16,000 attendees and 1,800 exhibitors from 74 countries – including an SCBIO-led delegation of 20+ from South Carolina --all who will be welcomed in a special, keynote address by ABC’s Robin Roberts. Read on for full details...
Industry subject matter experts to cover what businesses need to know about state industry see more
GREENVILLE, SC – February 14, 2018 – SCBIO will host a half-day program March 14, 2018 -- South Carolina Life Sciences Boot Camp: Essentials of a Growing Industry – to inform and update businesses and professionals from across the state on opportunities, trends and issues facing South Carolina’s fastest-growing industry segment.
To be held at the University of South Carolina’s Arnold School of Public Health in Columbia, the program will run from 8:30 a.m. until 12:30 p.m. and will feature a light breakfast followed by presentations from over half a dozen noted life sciences industry leaders. Confirmed presenters and their topics are:
- Burnie Maybank, Author of the SC Life Sciences Act; Partner, Nexsen Pruet, “Life Sciences industry Economic Development Incentives”
- Stephanie Yarbrough, Partner, Womble Bond Dickinson, “M&A 101 in the Life Sciences Space”
- Kathryn Cole Becker, Principal, Translational Science Solutions, “FDA 101 for Medical Devices”
- Jeff Stover, Partner, Haynsworth Sinkler Boyd, “IP Essentials for Life Sciences”
- John Osborne, Partner, Good Growth Capital, “Introduction to Life Science Innovation & Entrepreneurship”
- Public Policy Hot Topics – Speaker to be announced
Attendance is free to SCBIO members and employees of SCBIO member companies, and available for only $75 to Non-Members. Advance registration is required, and space is limited. To register, visit www.SCBIO.org/Events.
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.
SCBIO is the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations. SCBIO’s diverse membership is leading research and development of innovative healthcare, agricultural, industrial and environmental biotech and med-tech products that will make a difference across the Palmetto State, and around the world.
For additional information on SCBIO, visit www.SCBIO.org.
Ritedose investing $10MM to expand in South Carolina see more
COLUMBIA, S.C. – The Ritedose Corporation, a pharmaceutical products manufacturer, is once again expanding its Richland County operations with a $10 million investment.
Ritedose, which specializes in the production of inhalation products, eye drops, ear drops and oral liquids, has operated at Carolina Research Park for more than 20 years. In 2014, it expanded its operations and now plans to do so again with a new 140,000-square-foot facility at the Enterprise Industrial Campus of Midlands Technical College. Owned by the college, the business park is a 150-acre property off Powell Road in northeast Columbia, S.C.
For more information on The Ritedose Corporation, visit www.ritedose.com(link is external).
“This new facility represents the Ritedose Corporation’s continued commitment to Richland County, and is indicative of the company’s mission of maintaining our position as a global market leader.” –Ritedose President and CEO Umesh Dalvi
“To see a company like Ritedose choose to continue investing in our state is an important sign to the business community around the world that South Carolina is the place to be. We look forward to seeing the new heights the relationship between our state and this company will reach in the years to come.” –Gov. Henry McMaster
“We’re excited to see the continued success of our state’s thriving life sciences industry. I offer my congratulations to Ritedose Corporation on this tremendous achievement and look forward to supporting them as they grow and prosper in our state.” –Secretary of Commerce Bobby Hitt
“The Ritedose Corporation’s decision to invest in Richland County is further evidence of the attributes of doing business in our community.” –Richland County Council Chair Joyce Dickerson
“Economic development and workforce development are the cornerstone of our mission at Midlands Technical College, and we are happy to partner with The Ritedose Corporation as they expand on our Enterprise Campus.” –Midlands Technical College President Dr. Ron Rhames
FIVE FAST FACTS
- Ritedose Corporation is constructing a new Richland County facility.
- $10 million investment.
- Ritedose is a manufacturer of pharmaceutical products.
- The company will be constructing a new 140,000-square-foot facility at Midlands Technical College’s Enterprise Industrial Campus off Powell Road in Columbia, S.C.
- For more information on The Ritedose Corporation, visit www.ritedose.com
Top speakers and brands are committing to attend SCBIO 2017 in Charleston this October; have you sig see more
BIO global CEO Jim Greenwood will join South Carolina Governor Henry McMaster as featured luncheon speakers on the first full day of SCBIO 2017 – the annual conference bringing top leaders and executives from organizations across the life sciences industry to Charleston, South Carolina October 24–26.
Mr. Greenwood will be addressing the gathering with a keynote presentation entitled “Global Trends for the Life Sciences Industry – and Implications for South Carolina” at lunch on October 25. South Carolina Governor Henry McMaster will follow with a presentation entitled “Life Sciences Powered by Public/Private Partnership – A Strategic View from the Statehouse.”
Dozens of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, and industry supporters from across America have already committed to attend SCBIO 2017 at Charleston’s Gaillard Auditorium, organizers confirmed today. Among the committed speakers and panelists are Nephron Pharmaceuticals CEO Lou Kennedy, MUSC President David Cole, Clemson University President Jim Clements, USC President Harris Pastides, Medpoint CEO Chuck Crumpton, Belimed CEO Joseph McDonald, AVX Health Division executive Robert Fairey and numerous others.
Themed “Building the Business of Life SCiences in SC”, the 2+ day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio ag and more. While space is limited and advance registration is required, interested attendees can still register at http://scbio2017.eventbrite.com.
SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.
SCBIO 2017 kicks off Tuesday evening with a Welcome Reception for conference registrants, speakers and sponsors on the rooftop terrace of the Grand Bohemian Hotel. Wednesday will feature a full day of sessions beginning at breakfast with a greeting by Charleston Mayor John Tecklenburg and continuing through an evening reception. The conference will wrap up Thursday at lunchtime.
“The life sciences industry has become a major driver of South Carolina’s economy,” noted South Carolina Secretary of Commerce Bobby Hitt recently. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.” SC Commerce is a Founding Partner of SCBIO and of the Conference.
Among the leading biotech industry brands participating in the conference are Nephron Pharmaceutical, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, Softbox, NCGS and SEMDA. All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are attending, as is Greenville Health System and economic development entities including SCRA, the Upstate SC Alliance, the Charleston Regional Development Alliance and SiMT.
As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.